IL153540A0 - THE USE OF 7beta-HYDROXY-STEROID DERIVATIVES FOR THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONS - Google Patents

THE USE OF 7beta-HYDROXY-STEROID DERIVATIVES FOR THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONS

Info

Publication number
IL153540A0
IL153540A0 IL15354001A IL15354001A IL153540A0 IL 153540 A0 IL153540 A0 IL 153540A0 IL 15354001 A IL15354001 A IL 15354001A IL 15354001 A IL15354001 A IL 15354001A IL 153540 A0 IL153540 A0 IL 153540A0
Authority
IL
Israel
Prior art keywords
hydroxy
7beta
manufacture
pharmaceutical compositions
steroid derivatives
Prior art date
Application number
IL15354001A
Other languages
English (en)
Original Assignee
Hunter Fleming Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunter Fleming Ltd filed Critical Hunter Fleming Ltd
Publication of IL153540A0 publication Critical patent/IL153540A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL15354001A 2000-06-29 2001-06-29 THE USE OF 7beta-HYDROXY-STEROID DERIVATIVES FOR THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONS IL153540A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0016027A GB2363984A (en) 2000-06-29 2000-06-29 Protection against neuronal damage using 3-hydroxy-7 -hydroxy steroids and 3-oxo-7 -hydroxy steroids
PCT/GB2001/002929 WO2002000224A1 (en) 2000-06-29 2001-06-29 Neuroprotective 7-beta-hydroxysteroids

Publications (1)

Publication Number Publication Date
IL153540A0 true IL153540A0 (en) 2003-07-06

Family

ID=9894710

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15354001A IL153540A0 (en) 2000-06-29 2001-06-29 THE USE OF 7beta-HYDROXY-STEROID DERIVATIVES FOR THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONS
IL153540A IL153540A (en) 2000-06-29 2002-12-19 Use of steroids with group 7ß - hydroxy for the preparation of pharmaceutical preparations

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL153540A IL153540A (en) 2000-06-29 2002-12-19 Use of steroids with group 7ß - hydroxy for the preparation of pharmaceutical preparations

Country Status (23)

Country Link
US (2) US20030186953A1 (xx)
EP (1) EP1294381B1 (xx)
JP (1) JP2004501195A (xx)
KR (1) KR100829490B1 (xx)
CN (1) CN100441189C (xx)
AT (1) ATE303152T1 (xx)
AU (2) AU2001267705B2 (xx)
CA (1) CA2414583C (xx)
CY (1) CY1105371T1 (xx)
CZ (1) CZ305306B6 (xx)
DE (1) DE60113112T2 (xx)
DK (1) DK1294381T3 (xx)
ES (1) ES2247141T3 (xx)
GB (1) GB2363984A (xx)
HK (1) HK1052299B (xx)
HU (1) HU229265B1 (xx)
IL (2) IL153540A0 (xx)
NO (1) NO332089B1 (xx)
PL (1) PL200698B1 (xx)
RU (1) RU2258511C2 (xx)
SI (1) SI1294381T1 (xx)
WO (1) WO2002000224A1 (xx)
ZA (1) ZA200210214B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2363983A (en) 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone
GB2378898A (en) 2001-08-14 2003-02-26 Hunter Fleming Ltd Prophylactic and therapeutic use of hydroxysteroids
KR20050057086A (ko) * 2002-08-28 2005-06-16 홀리스-에덴 파마슈티칼즈, 인코포레이티드 치료적 처치 방법
GB0409498D0 (en) * 2004-04-28 2004-06-02 Hunter Fleming Ltd Transdermal steroid formulation
US7910755B2 (en) * 2004-09-29 2011-03-22 Harbor Biosciences, Inc. Stem cell expansion and uses
CA2588558A1 (en) * 2004-11-23 2006-06-01 Celgene Corporation Jnk inhibitors for treatment of cns injury
ES2662500T3 (es) 2006-11-21 2018-04-06 Asarina Pharma Ab El uso de esteroides de pregnano y androstano para la preparación de una composición farmacéutica para el tratamiento de trastornos del sistema nervioso central
US20100137270A1 (en) * 2006-11-30 2010-06-03 Hunter-Fleming Limited Modulation of prostaglandin/cyclooxygenase metabolic pathways
GB0623971D0 (en) * 2006-11-30 2007-01-10 Hunter Fleming Ltd Modulation of prostaglandin/cyclooxygenase metabolic pathways
CZ2008434A3 (cs) * 2008-07-10 2009-12-09 Ústav organické chemie a biochemie Akademie ved CR, v. v. i. Pregnanové anionické slouceniny, zpusob jejich výroby a jejich použití
CU20110244A7 (es) 2011-12-27 2013-08-29 Ct De Investigación Y Desarrollo De Medicamentos Cidem Sistemas espiroesteroidales con efectos neuroactivos y anti-inflamatorios
DE102012001361A1 (de) 2012-01-24 2013-07-25 Linde Aktiengesellschaft Verfahren zum Kaltgasspritzen
US20160362442A1 (en) * 2015-06-10 2016-12-15 IronMag Labs Method For DHEA Enanthate Processing

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292730A (en) * 1990-08-29 1994-03-08 Humanetics Corporation Modulation of immune system with Δ5-androstenes
FR2696934B1 (fr) * 1992-10-20 1995-06-02 Conservatoire Nal Arts Metiers Dérivés de stéroïdes naturels 3B hydroxyles ayant des propriétés de déclenchement et de stimulation de l'immunité, composition les contenant et procédé pour les obtenir.
SK103195A3 (en) * 1993-03-09 1996-12-04 Univ Utah Res Found Use of dehydroepiandrosterone derivative for pharmaceutical compositions production and pharmaceutical composition containing dehydroepiandrosterone derivative
ATE284895T1 (de) * 1995-06-06 2005-01-15 Euro Celtique Sa Neuroaktive steroide der androstan- und pregnanreihe
GB2317826B (en) * 1995-08-29 1999-12-15 Univ Edinburgh Regulation of intracellular glucocorticoid concentrations
US5985242A (en) * 1995-10-27 1999-11-16 Praecis Pharmaceuticals, Inc. Modulators of β-amyloid peptide aggregation comprising D-amino acids
EP0954317B1 (en) * 1996-04-09 2007-06-06 The University Of Edinburgh Use of 7 apha-substituted steroids to treat neuropsychiatric disorders
CN1222851A (zh) * 1996-04-09 1999-07-14 英国技术集团国际有限公司 7α－取代的类固醇用于治疗神经精神病、免疫或内分泌疾病的用途
EP1586584A1 (en) * 1996-08-27 2005-10-19 Praecis Pharmaceuticals Incorporated Modulators of beta-amyloid peptide aggregation comprising D-amino acids
WO1999015179A1 (en) * 1997-09-25 1999-04-01 Regents Of The University Of Minnesota Methods of limiting apoptosis of cells
WO1999024400A1 (en) * 1997-11-10 1999-05-20 Vyrex Corporation Probucol esters and uses thereof
CA2309855A1 (en) * 1997-11-24 1999-06-03 Katherine D. Gordon Testosterone inhibitors and use for the protection of neurons
WO1999052532A1 (en) * 1998-04-14 1999-10-21 Pharmadigm, Inc. Method for reducing central nervous system impairment
US20030083231A1 (en) * 1998-11-24 2003-05-01 Ahlem Clarence N. Blood cell deficiency treatment method
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
DE50014299D1 (de) * 1999-11-02 2007-06-14 Bayer Schering Pharma Ag 18-nor-steroide als selektiv wirksame estrogene
GB0003524D0 (en) * 2000-02-15 2000-04-05 Btg Int Ltd Cytoprotective steroids (II)
GB2363983A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone

Also Published As

Publication number Publication date
DK1294381T3 (da) 2005-10-31
PL359105A1 (en) 2004-08-23
CA2414583A1 (en) 2002-01-03
JP2004501195A (ja) 2004-01-15
AU2001267705B2 (en) 2005-08-18
RU2258511C2 (ru) 2005-08-20
HU229265B1 (en) 2013-10-28
KR100829490B1 (ko) 2008-05-16
AU6770501A (en) 2002-01-08
US20100130459A1 (en) 2010-05-27
HUP0301317A2 (hu) 2003-08-28
GB0016027D0 (en) 2000-08-23
ES2247141T3 (es) 2006-03-01
SI1294381T1 (sl) 2006-04-30
PL200698B1 (pl) 2009-01-30
CN100441189C (zh) 2008-12-10
NO332089B1 (no) 2012-06-18
EP1294381B1 (en) 2005-08-31
IL153540A (en) 2008-07-08
DE60113112T2 (de) 2006-07-13
CY1105371T1 (el) 2010-04-28
HK1052299B (zh) 2006-01-27
KR20030034112A (ko) 2003-05-01
CZ305306B6 (cs) 2015-07-22
GB2363984A (en) 2002-01-16
EP1294381A1 (en) 2003-03-26
US20030186953A1 (en) 2003-10-02
ATE303152T1 (de) 2005-09-15
HUP0301317A3 (en) 2006-06-28
WO2002000224A1 (en) 2002-01-03
NO20026244L (no) 2003-02-27
DE60113112D1 (de) 2005-10-06
CN1443071A (zh) 2003-09-17
NO20026244D0 (no) 2002-12-27
HK1052299A1 (en) 2003-09-11
ZA200210214B (en) 2004-03-17
CA2414583C (en) 2010-08-24

Similar Documents

Publication Publication Date Title
IL158041A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
IL152448A0 (en) 3-nitrogen-6, 7-dioxygen steroid derivatives and pharmaceutical compositions containing the same
IL152451A0 (en) 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
HK1061037A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2003229084A1 (en) Methods and formulations for the delivery of pharmacologically active agents
HRP20080467A2 (en) 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia
AU5326100A (en) Pharmaceutical compositions and methods for use
CY1105371T1 (el) Νευροπροστατευτικα 7-βητα-υδροξυστepοειδη
HUP0201872A3 (en) Steroid compounds and pharmaceutical compositions of the same
MXPA01011606A (es) Terapia anti-inflamatoria para infeccion mediada por inflamacion.
NO20013414L (no) Ny anvendelse av melagatran
IL153541A0 (en) The use of 7-hydroxyepiandrosterone for the manufacture of pharmaceutical compositions
IL156372A0 (en) Carbazole derivatives and pharmaceutical compositions containing the same
HK1061647A1 (en) Pharmaceutical compositions of rapmycins
IL156664A0 (en) Tacrolimus derivatives and pharmaceutical compositions containing the same
AU1899501A (en) Novel 3-nitropyridine derivatives and the pharmaceutical compositions containingsaid derivatives
AP2002002402A0 (en) Streptogramin derivatives production thereof and compositions containing the same
AU2001228784A1 (en) Inositol derivatives and their pharmaceutical use
AUPQ501000A0 (en) Compositions for the prevention and treatment of influenza

Legal Events

Date Code Title Description
KB Patent renewed